Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OneSource Specialty Pharma is a global Contract Development and Manufacturing Organization (CDMO) that provides integrated solutions for biologics, complex injectables, and specialized oral dosage forms. The company was established through the strategic consolidation of Stelis Biopharma, Steri-Science, and the softgel business of Strides Pharma Science, creating a scaled platform for high-growth pharmaceutical segments. OneSource operates advanced manufacturing facilities in India that are equipped with cutting-edge technology and maintain rigorous global regulatory certifications, including US FDA and EU GMP. Their service offerings encompass the entire product lifecycle, from process development and clinical supplies to large-scale commercial manufacturing. By leveraging a diverse portfolio of modalities such as monoclonal antibodies, vaccines, and liposomal formulations, OneSource serves as a critical partner to global biotech and pharmaceutical innovators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onesource Specialty.